Total Payments
$4,326
2024 Payments
$119.28
Companies
37
Transactions
183
Medicare Patients
1,160
Medicare Billing
$82,231
Payment Breakdown by Category
Food & Beverage$4,030 (93.2%)
Education$296.16 (6.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,030 | 178 | 93.2% |
| Education | $296.16 | 5 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $1,015 | 30 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $358.73 | 14 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $319.86 | 10 | $0 (2019) |
| Ipsen Biopharmaceuticals, Inc | $256.41 | 7 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $240.72 | 16 | $0 (2020) |
| Amgen Inc. | $220.89 | 8 | $0 (2021) |
| Lilly USA, LLC | $204.79 | 7 | $0 (2021) |
| Seattle Genetics, Inc. | $192.50 | 7 | $0 (2018) |
| Medtronic USA, Inc. | $173.75 | 1 | $0 (2018) |
| ABBVIE INC. | $160.68 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $119.28 | 5 | ABBVIE INC. ($119.28) |
| 2021 | $210.91 | 7 | Lilly USA, LLC ($118.60) |
| 2020 | $225.60 | 12 | Foundation Medicine, Inc. ($49.01) |
| 2019 | $724.43 | 39 | Genentech USA, Inc. ($214.00) |
| 2018 | $1,544 | 64 | Genentech USA, Inc. ($408.55) |
| 2017 | $1,502 | 56 | Genentech USA, Inc. ($392.09) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: ONCOLOGY | ||||||
| 07/19/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: ONCOLOGY | ||||||
| 05/06/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: ONCOLOGY | ||||||
| 03/19/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: ONCOLOGY | ||||||
| 01/11/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $31.28 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2021 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Oncology | ||||||
| 04/28/2021 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Oncology | ||||||
| 04/14/2021 | Lilly USA, LLC | CYRAMZA (Drug), RETEVMO | Education | In-kind items and services | $118.60 | General |
| Category: Oncology | ||||||
| 03/31/2021 | Dova Pharmaceuticals | Doptelet (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Hematology/Oncology | ||||||
| 03/18/2021 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Oncology | ||||||
| 01/28/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Oncology | ||||||
| 01/15/2021 | Epizyme, Inc., | TAZVERIK (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2020 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug), ONIVYDE | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Oncology/Endocrinology | ||||||
| 09/10/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Education | In-kind items and services | $7.25 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2020 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Oncology | ||||||
| 02/29/2020 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $49.01 | General |
| Category: ONCOLOGY | ||||||
| 02/12/2020 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Oncology | ||||||
| 02/06/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: ONCOLOGY | ||||||
| 02/05/2020 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Oncology | ||||||
| 01/30/2020 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Oncology | ||||||
| 01/23/2020 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: ONCOLOGY | ||||||
| 01/17/2020 | Astellas Pharma US Inc | PADCEV (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: ONCOLOGY | ||||||
| 01/16/2020 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: ONCOLOGY | ||||||
| 01/08/2020 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2019 | Genentech USA, Inc. | VENCLEXTA (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 316 | 427 | $78,366 | $14,928 |
| 2020 | 9 | 844 | 1,710 | $351,659 | $67,304 |
Total Patients
1,160
Total Services
2,137
Medicare Billing
$82,231
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 200 | 273 | $58,149 | $11,538 | 19.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 82 | 115 | $14,835 | $2,615 | 17.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 34 | 39 | $5,382 | $774.76 | 14.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 424 | 1,037 | $220,881 | $40,441 | 18.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 91 | 91 | $44,044 | $9,492 | 21.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 56 | 179 | $20,585 | $5,691 | 27.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 155 | 257 | $33,153 | $4,955 | 14.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 21 | 21 | $8,400 | $2,384 | 28.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 17 | 36 | $7,668 | $1,091 | 14.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 16 | 19 | $3,990 | $1,060 | 26.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 40 | 46 | $6,348 | $982.10 | 15.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 13 | $4,082 | $741.21 | 18.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 11 | $2,508 | $466.40 | 18.6% |
About Dr. Ronald Steis, MD
Dr. Ronald Steis, MD is a Hematology & Oncology healthcare provider based in Cumming, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205875218.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Steis, MD has received a total of $4,326 in payments from pharmaceutical and medical device companies, with $119.28 received in 2024. These payments were reported across 183 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,030).
As a Medicare-enrolled provider, Steis has provided services to 1,160 Medicare beneficiaries, totaling 2,137 services with total Medicare billing of $82,231. Data is available for 2 years (2020–2021), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Cumming, GA
- Active Since 06/05/2006
- Last Updated 09/18/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1205875218
Products in Payments
- Avastin (Biological) $323.95
- OPDIVO (Biological) $283.43
- VENCLEXTA (Biological) $271.44
- ADCETRIS (Biological) $252.88
- Onivyde (Drug) $197.16
- TECENTRIQ (Biological) $176.87
- OSTEOCOOL RF ABLATION (Device) $173.75
- KEYTRUDA (Biological) $173.38
- CYRAMZA (Drug) $167.32
- MEKINIST (Drug) $160.70
- KISQALI (Drug) $125.52
- VENCLEXTA (Drug) $119.28
- GAZYVA (Biological) $105.55
- FOUNDATIONONE (Device) $91.81
- Nplate (Biological) $82.80
- ZEJULA (Drug) $77.22
- Perjeta (Biological) $59.29
- Xtandi (Drug) $52.39
- Kyprolis (Biological) $48.76
- XTANDI (Drug) $48.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.